CAMPBELL, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — On November 10, 2020, VIVUS, Inc. (the “Company”), a biopharmaceutical company, filed the Second Amended Joint
Prepackaged Chapter 11 Plan of Reorganization of VIVUS, Inc. and Its Affiliated Debtors [Docket No. 339] (as may be amended, modified, or supplemented from time to time,
the “Plan”) with the United States Bankruptcy